Cargando…
The potential drug for treatment in pancreatic adenocarcinoma: a bioinformatical study based on distinct drug databases
BACKGROUND: The prediction of drug-target interaction from chemical and biological data can advance our search for potential drug, contributing to a therapeutic strategy for pancreatic adenocarcinoma (PAAD). We aim to identify hub genes of PAAD and search for potential drugs from distinct databases....
Autores principales: | Liu, Han, Zhou, Qi, Wei, Wenjuan, Qi, Bing, Zeng, Fen, Bao, Nabuqi, Li, Qian, Guo, Fangyue, Xia, Shilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079489/ https://www.ncbi.nlm.nih.gov/pubmed/32206083 http://dx.doi.org/10.1186/s13020-020-00309-x |
Ejemplares similares
-
The nine ADAMs family members serve as potential biomarkers for immune infiltration in pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2020) -
Bioinformatic evidences and analysis of putative biomarkers in pancreatic ductal adenocarcinoma
por: Gu, Yuan, et al.
Publicado: (2019) -
T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?
por: Zhou, Qi, et al.
Publicado: (2020) -
An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021) -
Pancreatic ductal deletion of S100A9 alleviates acute pancreatitis by targeting VNN1-mediated ROS release to inhibit NLRP3 activation
por: Xiang, Hong, et al.
Publicado: (2021)